Journal article
FloSeal: a new hemostyptic agent in peripheral vascular surgery.
- Reuthebuch O Clinic for Cardiovascular Surgery, University Hospital Zürich, Switzerland. oliver.reuthebuch@chi.usz.ch
- Lachat ML
- Vogt P
- Schurr U
- Turina M
- 2000-10-19
Published in:
- VASA. Zeitschrift fur Gefasskrankheiten. - 2000
Administration, Topical
Blood Loss, Surgical
Drug Combinations
Female
Gelatin
Hemostatics
Humans
Male
Thrombin
Vascular Diseases
English
BACKGROUND
Bleeding is a common and often severe side-effect in vascular surgery. The use of glue is widely accepted to achieve a dry surgical field. The application of sealant is limited when the surface is covered with blood. Aim of this study was to evaluate a new sealant (FloSeal) in patients undergoing vascular surgery.
PATIENTS AND METHODS
Between June 1998 and July 1999 a total of 17 patients with peripheral vascular interventions was included in this investigation. Effectiveness was measured by bleeding severity prior and after application, time to hemostasis, amount of fusion matrix necessary for hemostasis, the potential need for additional hemostatic measures, or the need for reoperations to control the bleeding.
RESULTS
In 15 out of 17 patients bleeding was controlled with FloSeal alone, two patients required further surgical or hemostatic treatment. There were no local or systemic complications after use of this product.
CONCLUSION
FloSeal is an advantageous hemostatic tool.
Bleeding is a common and often severe side-effect in vascular surgery. The use of glue is widely accepted to achieve a dry surgical field. The application of sealant is limited when the surface is covered with blood. Aim of this study was to evaluate a new sealant (FloSeal) in patients undergoing vascular surgery.
PATIENTS AND METHODS
Between June 1998 and July 1999 a total of 17 patients with peripheral vascular interventions was included in this investigation. Effectiveness was measured by bleeding severity prior and after application, time to hemostasis, amount of fusion matrix necessary for hemostasis, the potential need for additional hemostatic measures, or the need for reoperations to control the bleeding.
RESULTS
In 15 out of 17 patients bleeding was controlled with FloSeal alone, two patients required further surgical or hemostatic treatment. There were no local or systemic complications after use of this product.
CONCLUSION
FloSeal is an advantageous hemostatic tool.
- Language
-
- English
- Open access status
- closed
- Identifiers
-
- DOI 10.1024/0301-1526.29.3.204
- PMID 11037719
- Persistent URL
- https://sonar.ch/global/documents/72416
Statistics
Document views: 15
File downloads: